A Summary Of Safety Of Gadofosveset (Ms-325) At 0.03 Mmol/Kg Body Weight Dose - Phase Ii And Phase Iii Clinical Trials Data
INVESTIGATIVE RADIOLOGY（2006）
关键词
contrast agent, MR contrast media, MR angiography, safety, blood pool agent
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要